RT @aakriti_15: We look forward to randomized controlled trials investigating role of statins in different populations with COVID-19 includ…
We look forward to randomized controlled trials investigating role of statins in different populations with COVID-19 including outpatients, stable inpatients and ICU patients including https://t.co/PMYv8Jkg3g being led by @bbikdeli
Honored to be one of the study physicians on this project.
RT @bbikdeli: Preliminary results from #INSPIRATION RCT. An incredible journey to work w our pts, colleagues and advisors to generate high-…
RT @psadeghipour: Honored to communicate the preliminary results of INSPIRATION Trial along with my co-chair @bbikdeli. Thanks to our site…
RT @PabloDemelo: Ya están aquí los resultados (preliminares) del ensayo INSPIRATION: profilaxis con dosis estándar vs intermedias. NO hay b…
RT @psadeghipour: Honored to communicate the preliminary results of INSPIRATION Trial along with my co-chair @bbikdeli. Thanks to our site…
RT @psadeghipour: Honored to communicate the preliminary results of INSPIRATION Trial along with my co-chair @bbikdeli. Thanks to our site…
RT @bbikdeli: Preliminary results from #INSPIRATION RCT. An incredible journey to work w our pts, colleagues and advisors to generate high-…
RT @PabloDemelo: Ya están aquí los resultados (preliminares) del ensayo INSPIRATION: profilaxis con dosis estándar vs intermedias. NO hay b…
RT @PabloDemelo: Ya están aquí los resultados (preliminares) del ensayo INSPIRATION: profilaxis con dosis estándar vs intermedias. NO hay b…
RT @PabloDemelo: Ya están aquí los resultados (preliminares) del ensayo INSPIRATION: profilaxis con dosis estándar vs intermedias. NO hay b…
RT @PabloDemelo: Ya están aquí los resultados (preliminares) del ensayo INSPIRATION: profilaxis con dosis estándar vs intermedias. NO hay b…
RT @psadeghipour: Honored to communicate the preliminary results of INSPIRATION Trial along with my co-chair @bbikdeli. Thanks to our site…
RT @PabloDemelo: Ya están aquí los resultados (preliminares) del ensayo INSPIRATION: profilaxis con dosis estándar vs intermedias. NO hay b…
RT @psadeghipour: Honored to communicate the preliminary results of INSPIRATION Trial along with my co-chair @bbikdeli. Thanks to our site…
RT @psadeghipour: Honored to communicate the preliminary results of INSPIRATION Trial along with my co-chair @bbikdeli. Thanks to our site…
RT @PabloDemelo: Ya están aquí los resultados (preliminares) del ensayo INSPIRATION: profilaxis con dosis estándar vs intermedias. NO hay b…
RT @psadeghipour: Honored to communicate the preliminary results of INSPIRATION Trial along with my co-chair @bbikdeli. Thanks to our site…
RT @PabloDemelo: Ya están aquí los resultados (preliminares) del ensayo INSPIRATION: profilaxis con dosis estándar vs intermedias. NO hay b…
RT @PabloDemelo: Ya están aquí los resultados (preliminares) del ensayo INSPIRATION: profilaxis con dosis estándar vs intermedias. NO hay b…
RT @bbikdeli: Preliminary results from #INSPIRATION RCT. An incredible journey to work w our pts, colleagues and advisors to generate high-…
Ya están aquí los resultados (preliminares) del ensayo INSPIRATION: profilaxis con dosis estándar vs intermedias. NO hay beneficio clínico en el uso de dosis intermedias en pacientes críticos con COVID. A la espera de resultados definitivos, tocará revisar
RT @bbikdeli: Preliminary results from #INSPIRATION RCT. An incredible journey to work w our pts, colleagues and advisors to generate high-…
RT @psadeghipour: Honored to communicate the preliminary results of INSPIRATION Trial along with my co-chair @bbikdeli. Thanks to our site…
RT @psadeghipour: Honored to communicate the preliminary results of INSPIRATION Trial along with my co-chair @bbikdeli. Thanks to our site…
RT @bbikdeli: Preliminary results from #INSPIRATION RCT. An incredible journey to work w our pts, colleagues and advisors to generate high-…
@f_g_zampieri @MiguelrrMD @remap_cap @leticiakawano @iceman_ex @CritCareReviews the next few weeks are going to be very interesting:
Preliminary results from #INSPIRATION RCT. An incredible journey to work w our pts, colleagues and advisors to generate high-quality knowledge for #antithrombotic therapy in #ICU pts w #COVID-19.🙏🙏🙏 @psadeghipour Please stay tuned for full results! https:/
Honored to communicate the preliminary results of INSPIRATION Trial along with my co-chair @bbikdeli. Thanks to our site PIs, study physicians and our very distinguished advisory committee. https://t.co/4fRSSItdWR Design paper can be found at https://t.co/
@DJC6998 @DavidACohen3 @jameshorowitzmd @OrenFriedman @PERTConsortium @vic_tapson @SaraHegabMD @RosovskyRachel @DrHooksDO @YevgeniyBr @klinelab @Robert_Maholic @aakonc @johnfanikos @PhillipJGaryMD We are almost done with the analyses for #INSPIRATION RCT
Amazing work by @bbikdeli and colleagues. Looking forward to seeing the results of this important trial! @ColumbiaCardio @crfheart
Great work, @bbikdeli and colleagues!
Exciting news‼️ The INSPIRATION trial of intermediate vs. standard-dose #heparin for critically-ill pts w #COVID19 has completed its enrollment target (600)!✅ Kudos to the entire team! Here's the design paper. https://t.co/GjeKnp3Rz9
RT @bbikdeli: The optimal PPX #anticoagulation for ICU pts w #COVID-19 is unknown &❓ if statins can #thromboinflammation. Honored to be a…
⬆️dose #heparin in #COVID19 is not risk-free. Suspected #HIT in a @CircAHA study. No Fx assay.⬆️dose heparin needs #RCTs. @michaelTCTMD Summary of ongoing trials in the paper below (Table 2). Why no #RCTs with danaparoid @LaurentBertole1? #INSPIRATION ht
Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies - Thrombosis Research https://t.co/dVERs82cnd
RT @mmonrealriete: A great initiative from a team of Iranian doctors Very interesting You are more than welcome to share your findings wit…
RT @mmonrealriete: A great initiative from a team of Iranian doctors Very interesting You are more than welcome to share your findings wit…
RT @mmonrealriete: A great initiative from a team of Iranian doctors Very interesting You are more than welcome to share your findings wit…
RT @mmonrealriete: A great initiative from a team of Iranian doctors Very interesting You are more than welcome to share your findings wit…
A great initiative from a team of Iranian doctors Very interesting You are more than welcome to share your findings with all of us AddThis | Home https://t.co/EYAemRXYMy
RT @LiverpoolCCS: Intermediate versus standard-dose prophylactic #anticoagulation and #statin therapy versus placebo in critically-ill pati…
RT @bbikdeli: @cphend Thank you! Here's the link to the article. https://t.co/GjeKnoMgHB
@cphend Thank you! Here's the link to the article. https://t.co/GjeKnoMgHB
So proud to be a part of this clinical trial. Thanks to @pooya_mehr for giving me the opportunity and @psadeghipour @bbikdeli for their guidance.
RT @MVMadhavanMD: Truly an amazing and enormous effort by my former co-fellow @bbikdeli and colleagues to design and initiate this importan…
RT @bbikdeli: The optimal PPX #anticoagulation for ICU pts w #COVID-19 is unknown &❓ if statins can #thromboinflammation. Honored to be a…
RT @MVMadhavanMD: Truly an amazing and enormous effort by my former co-fellow @bbikdeli and colleagues to design and initiate this importan…
RT @LiverpoolCCS: Intermediate versus standard-dose prophylactic #anticoagulation and #statin therapy versus placebo in critically-ill pati…
RT @bbikdeli: The optimal PPX #anticoagulation for ICU pts w #COVID-19 is unknown &❓ if statins can #thromboinflammation. Honored to be a…
Intermediate versus standard-dose prophylactic #anticoagulation and #statin therapy versus placebo in critically-ill patients with COVID-19: Rationale & design of the INSPIRATION/INSPIRATION-S studies https://t.co/C3IMAxPR06 https://t.co/iVLjnvmfna
RT @bbikdeli: The optimal PPX #anticoagulation for ICU pts w #COVID-19 is unknown &❓ if statins can #thromboinflammation. Honored to be a…
RT @bbikdeli: The optimal PPX #anticoagulation for ICU pts w #COVID-19 is unknown &❓ if statins can #thromboinflammation. Honored to be a…
RT @bbikdeli: The optimal PPX #anticoagulation for ICU pts w #COVID-19 is unknown &❓ if statins can #thromboinflammation. Honored to be a…
RT @bbikdeli: The optimal PPX #anticoagulation for ICU pts w #COVID-19 is unknown &❓ if statins can #thromboinflammation. Honored to be a…
RT @bbikdeli: The optimal PPX #anticoagulation for ICU pts w #COVID-19 is unknown &❓ if statins can #thromboinflammation. Honored to be a…
RT @bbikdeli: The optimal PPX #anticoagulation for ICU pts w #COVID-19 is unknown &❓ if statins can #thromboinflammation. Honored to be a…
RT @bbikdeli: The optimal PPX #anticoagulation for ICU pts w #COVID-19 is unknown &❓ if statins can #thromboinflammation. Honored to be a…
Truly an amazing and enormous effort by my former co-fellow @bbikdeli and colleagues to design and initiate this important trial. Looking forward to seeing the results!! @ColumbiaCardio @NYPCUCVI
RT @bbikdeli: The optimal PPX #anticoagulation for ICU pts w #COVID-19 is unknown &❓ if statins can #thromboinflammation. Honored to be a…
RT @bbikdeli: The optimal PPX #anticoagulation for ICU pts w #COVID-19 is unknown &❓ if statins can #thromboinflammation. Honored to be a…
RT @bbikdeli: The optimal PPX #anticoagulation for ICU pts w #COVID-19 is unknown &❓ if statins can #thromboinflammation. Honored to be a…
Honored to be part of INSPIRATION @AzitaTalasaz @AAmin_cardio @SepehrJamalkha1
RT @bbikdeli: The optimal PPX #anticoagulation for ICU pts w #COVID-19 is unknown &❓ if statins can #thromboinflammation. Honored to be a…
The optimal PPX #anticoagulation for ICU pts w #COVID-19 is unknown &❓ if statins can #thromboinflammation. Honored to be a part of INSPIRATION/INSPIRATION-S studies. We also summarize other #RCTs. https://t.co/gxxagrziiR @psadeghipour @BrighamWomens
@LiverpoolCCS contribution to research into #COVID19: Intermediate versus standard-dose prophylactic #anticoagulation and #statin therapy versus placebo in critically-ill patients with COVID-19: Rationale & design of the INSPIRATION/INSPIRATION-S studi